Around one in four patients with brain injury who are unresponsive to verbal commands perform cognitive tasks detectable on fMRI or EEG, which is more prevalent than previously thought.
Early trials of a new oral Factor XIa inhibitor (Milvexian) are showing promise for prevention of thrombotic events in patients with acute stroke, acute coronary syndrome, and atrial fibrillation.
Rapid advances in stroke treatment are driving the evolution of time-critical hyperacute stroke services. Explore case studies and the elements of well-functioning systems.
Mechanical thrombectomy has rapidly become the gold standard for treating acute ischemic stroke caused by large vessel occlusion, and indications for its use continue to expand at breathtaking pace.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
Diagnosing myasthenic crisis with atypical presentation is very challenging, especially in elderly patients who can present with isolated dysarthria, suggesting lacunar stroke.
Eagle’s syndrome – an elongated styloid process – is an unusual cause of carotid artery dissection. Endovascular intervention is rare but can rapidly restore hemodynamic compression and enable intracranial thrombectomy.
Subclavian artery stenting is safe and may be helpful in patients with cerebral perfusion deficiency caused by intractable acute carotid occlusion coexisting with subclavian steal.
Neuroimaging plays an increasingly critical role in clinical practice. PET Pearls is an interactive activity designed to improve your confidence and accuracy when interpreting imaging for early signs of cognitive impairment.
Despite the range of body sizes in children, few ventricular assist devices (VAD) exist to support pediatric patients with end-stage heart failure. Large registry data identified weight < 20 kg to be associated with higher rates of VAD-related …
Traditionally, the management of atrial fibrillation (AF) seeks to address two primary goals – symptom control and stroke prevention. Over the past decade, the therapeutic armamentarium for AF management has expanded. For stroke prevention, direct …
Coronary artery disease (CAD), cerebrovascular disease, and peripheral arterial disease (PAD) are all clinical manifestations of systemic atherosclerosis. In patients with these atherosclerotic diseases, the platelet aggregation inhibitor …
Atrial fibrillation (AF) increases the risk of ischemic stroke by more than fivefold, and more than 90% of AF-related stroke originates from the left atrial appendage (LAA) [ 1 , 2 ]. Oral anticoagulation (OAC) remains the cornerstone to mitigating …
About 50% of stroke patients have an unfavorable outcome. Predicting outcome is challenging but is key to understanding how best to treat patients.
Prof Susanne Wegener discusses her team’s work to develop deep learning models that outperform neurologists when predicting outcome based on imaging data alone or in combination with clinical data.
Atherosclerosis is a chronic arterial disease and a major cause of vascular mortality. The disease has a latency of many years, its major clinical manifestations include ischemic stroke or transient ischemic attack (IS/TIA), acute coronary …
Coronary artery disease (CAD), cerebrovascular disease, and peripheral arterial disease (PAD) are all clinical manifestations of systemic atherosclerosis. In patients with these atherosclerotic diseases, the platelet aggregation inhibitor …
As the leading cause of acquired adult disability, the third leading cause of death, stroke is a public health problem. Acute-phase therapeutic strategies such as thrombolysis and thrombectomy have improved functional prognosis. However, only 15% …
Up to 38% of acute ischemic strokes (AIS) are caused by intracranial large vessel occlusion (LVO) [ 1 ]. Endovascular treatment (EVT) has become the cornerstone of treatment, with evidence well established after the publication of positive results …
Early trials of a new oral Factor XIa inhibitor (Milvexian) are showing promise for prevention of thrombotic events in patients with acute stroke, acute coronary syndrome, and atrial fibrillation.
